LC-MS/TOF, LC-MSn, on-line H/D exchange and LC-NMR studies on rosuvastatin degradation and in silico determination of toxicity of its degradation products: a comprehensive approach during drug development-Reference-Cited by-同舟云学术

LC-MS/TOF, LC-MSn, on-line H/D exchange and LC-NMR studies on rosuvastatin degradation and in silico determination of toxicity of its degradation products: a comprehensive approach during drug development

Published:2013-02-06 Issue:10 Volume:405 Page:3215-3231
ISSN:1618-2642
Container-title:Analytical and Bioanalytical Chemistry
language:en
Short-container-title:Anal Bioanal Chem

Author:

Shah Ravi P.,Sahu Archana,Singh Saranjit

Publisher

Springer Science and Business Media LLC

Subject

Biochemistry,Analytical Chemistry

Link

http://link.springer.com/content/pdf/10.1007/s00216-013-6760-1.pdf

Reference33 articles.

1. ICH (2003) Stability testing of new drug substances and products Q1A(R2). International Conference on Harmonisation, IFPMA, Geneva

2. WHO (2009) Stability testing of active pharmaceutical ingredients and finished pharmaceutical products. Technical Report Series No. 953. World Health Organization, Geneva

3. Singh S, Handa T, Narayanam M, Sahu A, Junwal M, Shah RP (2012) J Pharm Biomed Anal 69:148–173

4. ICH (2009) Pharmaceutical development Q8(R2). International Conference on Harmonisation, IFPMA, Geneva

5. Gao T, Liu Y, Ji Y, Wu X, Xu J (2012) J Pharm Biomed Anal 66:381–386

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An amalgamation of LC-MS HDX and AI-based software for structure prediction of drug degradation products: An integrated step towards pharmaceutical development;Analytical Chemistry Letters;2024-04-11

2. Development of stability‐indicating assay method and liquid chromatography‐quadrupole‐time‐of‐flight mass spectrometry‐based structural characterization of the forced degradation products of alpelisib;Biomedical Chromatography;2023-12-26

3. Stability of API as a Key Parameter for New Formulations Development - A Case Study of Rosuvastatin Calcium;Acta Poloniae Pharmaceutica - Drug Research;2023-11-21

4. Insight into the photolytic degradation products of Rosuvastatin: Full chiral and structural elucidation and conversion kinetics by a combined chromatographic, spectroscopic and theoretical approach;Journal of Pharmaceutical and Biomedical Analysis;2023-11

5. Characterization of Degradation Products and Drug–Excipient Interaction Products of Erdafitinib by LC–Q-TOF-MS/MS and NMR;Chromatographia;2023-07-14